Implementation of Bright Light Therapy ID

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

105 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-10-18

Study Completion Date

2026-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Many adults with intellectual disabilities (ID) have depressive symptoms, which negatively impact their quality of life. A lot of of the non-medicinal forms of treatment are not or hardly suitable for people with ID. Bright light therapy (BLT) seems to be a good option. Earlier research has shown that BLT is applicable in this group and seems promising in terms of reducing depressive symptoms, without serious side effects.

In part 1 of this project we investigate the implementation of BLT at Amarant. We will take the lessons learned into part 2 of this project: the implementation of BLT at Abrona. We will evaluate this process and the outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Seeing the Light: Early Intervention in People at Risk for Bipolar Disorder

NCT06282250

Bipolar Disorder Mood Swing Prodromal Symptoms

RECRUITING NA

Cognitive-behavioral Therapy vs. Light Therapy for Preventing SAD Recurrence

NCT01714050

Seasonal Affective Disorder (SAD) Winter Depression Major Depressive Disorder, Recurrent, With Seasonal Pattern

COMPLETED NA

Optimizing Long-Term Outcomes for Winter Depression With CBT-SAD and Light Therapy

NCT03691792

Seasonal Affective Disorder

COMPLETED NA

Bright Start Study

NCT05356130

Depression

COMPLETED NA

Prevention of Comorbid Depression and Obesity in Attention-deficit/ Hyperactivity Disorder

NCT03371810

Attention-Deficit / Hyperactivity Disorder Depression Obesity

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depressive Symptoms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Persons involved in BLT

Persons with ID and staff who are involved in BLT. Either by receiving BLT, or by prescribing or facitating BLT.

Bright light therapy

Intervention Type OTHER

for 2 weeks the patient will take place for a 10.000lux lamp for 20-30 minutes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bright light therapy

for 2 weeks the patient will take place for a 10.000lux lamp for 20-30 minutes.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Involved in the implementation of BLT (staff) OR
* Involved in the prescription or application of BLT (staff/relatives) OR
* receiving BLT for their depressive symptoms (patients with ID)
* 18 years or older
* informed consent